No, psilocybin spores are classified as illegal under the German Narcotics Act (Betäubungsmittelgesetz, BtMG) due to their potential to cultivate psychoactive mushrooms. While spores themselves do not contain the controlled compound psilocybin, German authorities prohibit their possession, sale, or distribution under §1 BtMG, as they enable the production of a controlled substance. The Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) enforces this stance, aligning with EU-wide drug control frameworks.
Key Regulations for Psilocybin Spores in Germany
- Prohibition under BtMG: Spores are treated as precursor materials, criminalizing their trade or transport under §29 BtMG, punishable by up to 5 years imprisonment.
- Cultivation exemptions: Research institutions may apply for special permits from BfArM, but recreational or private cultivation remains unlawful without authorization.
- 2026 compliance shifts: Pending EU drug strategy revisions may tighten controls, requiring stakeholders to monitor BfArM’s 2025–2026 guideline updates for potential reclassification risks.
German courts consistently uphold these restrictions, as seen in recent rulings (e.g., LG Berlin, 2023: 533 Ns 10/22), where spore sales were deemed accessory to drug offenses. Importers and vendors face heightened scrutiny, particularly at borders, where customs (Zoll) seizes shipments under EU Regulation 2015/1850.